Privia Health Group, Inc. (NASDAQ:PRVA) Receives $28.58 Average Price Target from Analysts

Privia Health Group, Inc. (NASDAQ:PRVA) has received an average rating of “Moderate Buy” from the fourteen research firms that are presently covering the company, MarketBeat reports. Two investment analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating on the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $28.5833.

A number of research firms recently weighed in on PRVA. Barclays increased their price target on Privia Health Group from $23.00 to $24.00 and gave the company an “equal weight” rating in a research note on Tuesday, May 27th. Stephens restated an “overweight” rating and set a $32.00 target price on shares of Privia Health Group in a research note on Thursday, September 4th. Zacks Research raised shares of Privia Health Group from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 19th. Piper Sandler lowered their price target on shares of Privia Health Group from $36.00 to $35.00 and set an “overweight” rating on the stock in a report on Monday, August 11th. Finally, JMP Securities boosted their price objective on Privia Health Group from $29.00 to $30.00 and gave the stock a “market outperform” rating in a report on Friday, August 29th.

Privia Health Group Stock Performance

Shares of NASDAQ:PRVA opened at $22.21 on Monday. The company has a 50-day simple moving average of $21.17 and a 200 day simple moving average of $22.49. The company has a market capitalization of $2.73 billion, a P/E ratio of 201.93, a price-to-earnings-growth ratio of 3.24 and a beta of 0.82. Privia Health Group has a 52-week low of $16.47 and a 52-week high of $26.09.

Privia Health Group (NASDAQ:PRVA) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.05 by ($0.03). Privia Health Group had a net margin of 0.78% and a return on equity of 2.13%. The business had revenue of $521.15 million during the quarter, compared to the consensus estimate of $466.97 million. During the same quarter in the prior year, the company earned $0.19 EPS. Privia Health Group’s quarterly revenue was up 23.4% on a year-over-year basis. Privia Health Group has set its FY 2025 guidance at EPS. As a group, equities analysts forecast that Privia Health Group will post 0.14 earnings per share for the current year.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. CWM LLC grew its stake in shares of Privia Health Group by 50.3% in the first quarter. CWM LLC now owns 1,804 shares of the company’s stock valued at $40,000 after acquiring an additional 604 shares in the last quarter. Bessemer Group Inc. grew its position in shares of Privia Health Group by 2,393.4% during the 1st quarter. Bessemer Group Inc. now owns 2,269 shares of the company’s stock worth $51,000 after purchasing an additional 2,178 shares in the last quarter. Russell Investments Group Ltd. increased its holdings in shares of Privia Health Group by 2,852.2% during the first quarter. Russell Investments Group Ltd. now owns 2,657 shares of the company’s stock worth $60,000 after purchasing an additional 2,567 shares during the period. GAMMA Investing LLC raised its position in shares of Privia Health Group by 113.1% in the first quarter. GAMMA Investing LLC now owns 2,866 shares of the company’s stock valued at $64,000 after buying an additional 1,521 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd raised its position in shares of Privia Health Group by 2,115.3% in the first quarter. Caitong International Asset Management Co. Ltd now owns 3,323 shares of the company’s stock valued at $75,000 after buying an additional 3,173 shares in the last quarter. Institutional investors own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.